Trial Profile
Sitagliptin vs saxagliptin in patients with type 2 diabetes mellitus inadequately controlled with metformin alone
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Oct 2012
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary) ; Sitagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Oct 2012 New trial record
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.